×÷Õß:³ÇÊÐÍø À´Ô´:³ÇÊÐÍøÑ§Ôº ¸üÐÂÈÕÆÚ£º2013-6-15
ͬһҩÎï¿ÉÓв»Í¬¼ÁÐÍÊÊÓÃÓÚ²»Í¬¸øÒ©Í¾¾¶¡£²»Í¬¸øÒ©Í¾¾¶Ò©ÎïµÄÎüÊÕËٶȲ»Í¬£¬Ò»°ã¹æÂÉÊǾ²Âö×¢Éä>£¨¿ìÓÚ£©ÎüÈë>¼¡Èâ×¢Éä>ƤÏÂ×¢Éä>¿Ú·þ>¾¸Ø>ÌùƤ¡£²»Í¬Ò©¼ÁËùº¬µÄÒ©Á¿ËäÈ»ÏàµÈ£¬¼´Ò©¼Áµ±Á¿£¨pharmaceutical equivalance£© Ïàͬ£¬Ò©Ð§Ç¿¶È²»¾¡ÏàµÈ¡£Òò´ËÐèÒªÓÃÉúÎïµ±Á¿£¨bioequivalance£©£¬¼´Ò©Îï²»Í¬ÖÆ¼ÁÄÜ´ïµ½ÏàͬѪҩŨ¶ÈµÄ¼ÁÁ¿±ÈÖµ£¬×÷Ϊ±È½Ï±ê×¼¡£²»Í¬Ò©Îï¼ÁÐÍ£¬ÆäÖÐÒ©Îï¼ÁÁ¿²»Í¬£¬Ó¦ÓÃʱÒàӦעÒâÇø·ÖÑ¡Ôñ¡£ÏõËá¸ÊÓ;²Âö×¢Éä5¡«10¦Ìg£¬ÉàϺ¬¶§0.2¡«0.4mg,¿Ú·þ2.5¡«5mg£¬ÌùƤ10mg£¬¼ÁÁ¿Ïà²î¸ü´ó¡£½üÄêÀ´ÉúÎïÒ©Ñ§Ëæ×ÅÒ©¶¯Ñ§µÄ·¢Õ¹£¬ÎªÁÙ´²ÓÃÒ©ÌṩÁËÐí¶àеļÁÐÍ¡£ »ºÊÍÖÆ¼Á£¨slow release preparation£©ÀûÓÃÎÞÒ©Àí»îÐԵĻùÖÊ»ò°üÒÂ×èÖ¹Ò©ÎïѸËÙÈܳöÒÔ´ïµ½±È½ÏÎȶ¨¶ø³Ö¾ÃµÄÁÆÐ§¡£¿Ú·þ»ºÊÍÆ¬¼Á»ò½ºÄÒÿÈÕÒ»´Î¿Éά³ÖÓÐЧѪҩŨ¶ÈÒ»Ìì¡£³¦Íâ¸øÒ©³ýÒ»°ãÓÍÈܳ¤Ð§×¢Éä¼ÁÍ⻹ÓпØÊÍÖÆ¼Á£¨controlled release preparation£©¿ÉÒÔ¿ØÖÆÒ©Îï°´Áã¼¶¶¯Á¦Ñ§ºãËÙÊÍ·Å£¬ºãËÙÎüÊÕ¡£ÀýÈçÏõËá¸ÊÓÍÌùƤ¼ÁÿÈÕÌùÒ»´Î¡£Æ¥Â³¿¨Æ·ÑÛÆ¬ÖýáĤÄÒÄÚÿÖÜÒ»´Î¡£×Ó¹¬ÄÚ±ÜÔмÁÿÄê·ÅÖÃÒ»´Î¡£²»½ö±£Ö¤³¤ÆÚÁÆÐ§£¬Ò²´ó´ó·½±ãÁ˲¡ÈË¡£
|